Skip to main content
logo
SK bioscience Co.,Ltd. (KRX:302440)
South Korea flag South Korea · Delayed Price · Currency is KRW
48,900
-450 (-0.91%)
Last updated: Sep 9, 2025, 2:48 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Vaccines and Biopharmaceuticals
267.55B
Log In
Log In
Log In
Log In
Upgrade
Vaccines and Biopharmaceuticals Growth
-27.59%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
South Korea
131.49B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
-16.89%
Log In
Log In
Log In
Log In
Upgrade
Europe
107.12B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
405.26%
Log In
Log In
Log In
Log In
Upgrade
America
24.80B
Log In
Log In
Log In
Log In
Upgrade
America Growth
-86.66%
Log In
Log In
Log In
Log In
Upgrade
Asia
3.55B
Log In
Log In
Log In
Log In
Upgrade
Asia Growth
-8.81%
Log In
Log In
Log In
Log In
Upgrade
Middle East
576.98M
Log In
Log In
Log In
Log In
Upgrade
Middle East Growth
149.11%
Log In
Log In
Log In
Log In
Upgrade